Japanese government

The firm's ROS1 gene fusion kit was approved as a companion diagnostic for Pfizer's Xalkori.

The Japan Times says regulations are needed to oversee human genome-editing research.

Got to Get Ahead

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Japan is creating its first biosafety level-4 lab in response to concerns about the Ebola outbreak, Nature News reports.

The center, based in Yokohama, Japan, will likely purchase at least one single-molecule sequencer in order to avoid PCR-induced bias in Cap Analysis of Gene Expression, a method its researchers developed.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.